OCCUPATIONAL THERAPY CREATES PROFOUND IMPACTS ON CLIENT AND PATIENT LIVES
Margeaux Bartholomew-Carle
Occupational Therapist &
Chief Executive Officer, Ardant
PEOPLE IN HEALTH CARE
Filmed in Adelaide, South Australia | December 2024
In Australia, access to allied health services such as occupational therapy is increasingly challenging. Barriers like long wait times affect over 600,000 National Disability Insurance Scheme (NDIS) and 1.5 million aged care participants. With both cohorts expected to grow exponentially in coming years, the pressure on an already stretched system is set to increase.
Australian Health Journal met with one Occupational Therapist who encourages those entering the profession to embrace continuous learning and seek mentorship to maximise their impact on clients’ lives. Through her company she has a nation-wide mission to transform client access to allied health services like occupational therapy using artificial intelligence (AI).
Margeaux Bartholomew-Carle is an Adelaide based registered Occupational Therapist and the Founder and CEO of Ardant.
Throughout her career, Margeaux has worked in various settings, including aged care, disability, assistive technology, prescription, and mental health. This diverse experience has deepened her understanding of the different needs among client groups.
A significant turning point came when she worked as a solo practitioner and realised that the heavy administrative burden often kept her from important family moments, especially while her father was in the hospital with advanced prostate cancer. This experience motivated her to establish Ardant, focused on enabling OTs to prioritise client care over administrative tasks.
Under her leadership, Ardant has created an all-in-one online practice management platform designed to reduce administrative burdens for independent occupational therapists across Australia, ultimately enhancing access to OT services and improving client outcomes.
Margeaux believes that the role of occupational therapists is gaining recognition, particularly with the introduction of the NDIS, but acknowledges there are persistent misconceptions about the profession. To raise awareness, she advocates for targeted campaigns to educate GPs, health professionals, and the public about the value of OT in primary healthcare.
-
National Cancer Plan activates Australian Comprehensive Cancer Network
The landscape of cancer care in Australia is set to transform with the Australian Government launch in May 2024 of the Australian Comprehensive Cancer Network (ACCN) at the Innovations Showcase event, hosted by Cancer Australia in Sydney, Australia.
The ACCN is a nationally integrated system of cancer care, aimed at enhancing patient experiences and outcomes through coordinated and equitable access, by linking to comprehensive cancer services across Australia. Anchored by Comprehensive Cancer Centres (CCCs), the ACCN strives to deliver evidence-driven prevention, diagnosis, treatment, and support to all Australians affected by cancer.
-
Updated handbook on chronic kidney disease management in primary care
Kidney Health Australia’s latest kidney disease guide for primary care practitioners is expected to be pivotal in slowing down the rates of kidney failure, which have doubled in the past 20 years and if left unchecked will grow by a further 42% by 2030, according to the health charity.
With specific reference to new kidney treatments and culturally safe kidney care for First Nations Australians, the 5th edition of Chronic Kidney Disease (CKD) Management in Primary Care handbook, known as the ‘kidney bible’, is a significant step-up in enabling earlier diagnosis of kidney disease for GPs and other front-line healthcare professionals.
-
Ensuring stringent quality standards in the lifecycle of medical devices
Dr Jasjit Baveja is the Associate Director of Policy at the Medical Technology Association of Australia (MTAA), where she oversees regulatory affairs, clinical code of practice, procurement, industry policy, reimbursement, and advocacy. With over 20 years of experience in the medical device regulatory space, Dr Bavej’s expertise lies in providing educational opportunities for regulatory professionals in Australia to ensure continuous learning and professional development. She collaborates closely with the Therapeutic Goods Administration (TGA) to run workshops that provide invaluable experience, networking opportunities, and skill enhancement.
